trending Market Intelligence /marketintelligence/en/news-insights/trending/rd43kr6gmafhbe45qqljdg2 content esgSubNav
In This List

Intec Pharma to delist shares from Tel Aviv bourse

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Intec Pharma to delist shares from Tel Aviv bourse

Intec Pharma Ltd. will voluntarily delist its ordinary shares from the Tel Aviv Stock Exchange.

The delisting will take place in three months, with the shares continuing to trade on the exchange in the interim.

The Jerusalem-based drug developer's shares will remain listed on the Nasdaq Capital Market, and will transfer shares trading in Tel Aviv to the U.S. exchange.